Literature DB >> 21182263

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Qing-Rong Chen1, Li-Rong Yu, Patricia Tsang, Jun S Wei, Young K Song, Adam Cheuk, Joon-Yong Chung, Stephen M Hewitt, Timothy D Veenstra, Javed Khan.   

Abstract

MicroRNA 34a (miR-34a) is a potential tumor suppressor gene and has been identified as a miRNA component of the p53 network. To better understand the biological pathways involved in miR-34a action, a parallel global protein and mRNA expression profiling on miR-34a treated neuroblastoma cells (IMR32) was performed using isotope-coded affinity tags (ICAT) and Affymetrix U133plus2 microarray, respectively. Global profiling showed that miR-34a causes much smaller mRNA expression changes compared to changes at the protein level. A total of 1495 proteins represented by two or more peptides were identified from the quantitative ICAT analysis, of which 143 and 192 proteins are significantly up- or down-regulated by miR-34a, respectively. Pathway analysis of these differentially expressed proteins showed the enrichment of apoptosis and cell death processes in up-regulated proteins but DNA replication and cell cycle processes in the down-regulated proteins. Ribosomal proteins are the most significant set down-regulated by miR-34a. Additionally, biological network analysis to identify direct interactions among the differentially expressed proteins demonstrated that the expression of the ubiquitous transcription factor YY1, as well as its downstream proteins, is significantly reduced by miR-34a. We further demonstrated that miR-34a directly targets YY1 through a miR-34a-binding site within the 3' UTR of YY1 using a luciferase reporter system. YY1 is a negative regulator of p53, and it plays an essential role in cancer biology. Therefore, YY1 is another important direct target of miR-34a which closely regulates TP53 activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182263      PMCID: PMC3679541          DOI: 10.1021/pr1006697

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  33 in total

Review 1.  microRNAs join the p53 network--another piece in the tumour-suppression puzzle.

Authors:  Lin He; Xingyue He; Scott W Lowe; Gregory J Hannon
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

2.  Proteomics joins the search for microRNA targets.

Authors:  Helge Grosshans; Witold Filipowicz
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

3.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

Authors:  C Welch; Y Chen; R L Stallings
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

Review 4.  p53 enters the microRNA world.

Authors:  Heiko Hermeking
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

5.  Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.

Authors:  Hiroshi Tazawa; Naoto Tsuchiya; Masashi Izumiya; Hitoshi Nakagama
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

6.  A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.

Authors:  Kristina A Cole; Edward F Attiyeh; Yael P Mosse; Michael J Laquaglia; Sharon J Diskin; Garrett M Brodeur; John M Maris
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

7.  p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

Authors:  Guido T Bommer; Isabelle Gerin; Ying Feng; Andrew J Kaczorowski; Rork Kuick; Robert E Love; Yali Zhai; Thomas J Giordano; Zhaohui S Qin; Bethany B Moore; Ormond A MacDougald; Kathleen R Cho; Eric R Fearon
Journal:  Curr Biol       Date:  2007-07-26       Impact factor: 10.834

Review 8.  The guardian's little helper: microRNAs in the p53 tumor suppressor network.

Authors:  Xingyue He; Lin He; Gregory J Hannon
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

9.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Authors:  Nina Raver-Shapira; Efi Marciano; Eti Meiri; Yael Spector; Nitzan Rosenfeld; Neta Moskovits; Zvi Bentwich; Moshe Oren
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

10.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

View more
  51 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  Developing therapeutic microRNAs for cancer.

Authors:  A G Bader; D Brown; J Stoudemire; P Lammers
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

Review 3.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 4.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

Review 5.  The role of noncoding RNAs in epithelial cancer.

Authors:  Massimiliano Agostini; Carlo Ganini; Eleonora Candi; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-12

6.  Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.

Authors:  Markus Kaller; Sven-Thorsten Liffers; Silke Oeljeklaus; Katja Kuhlmann; Simone Röh; Reinhard Hoffmann; Bettina Warscheid; Heiko Hermeking
Journal:  Mol Cell Proteomics       Date:  2011-05-12       Impact factor: 5.911

7.  Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.

Authors:  Christina M Ward; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-02

Review 8.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

9.  Expression level of human miR-34a correlates with glioma grade and prognosis.

Authors:  Haifeng Gao; Hongyang Zhao; Wei Xiang
Journal:  J Neurooncol       Date:  2013-03-26       Impact factor: 4.130

Review 10.  Relative quantification of biomarkers using mixed-isotope labeling coupled with MS.

Authors:  Heidi M Chapman; Katherine L Schutt; Emily M Dieter; Shane M Lamos
Journal:  Bioanalysis       Date:  2012-10       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.